Get the Stockscreener App
0.5149
57.80%
-0.7051
After Hours:
.47
-0.0449
-8.72%
Aditxt Inc stock is traded at $0.5149, with a volume of 12.49M.
It is down -57.80% in the last 24 hours and down -93.85% over the past month.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues. The company operates in one segment, which is focused on the discovery and development of biopharmaceutical products.
See More
Previous Close:
$1.22
Open:
$0.79
24h Volume:
12.49M
Relative Volume:
43.62
Market Cap:
$262.66K
Revenue:
$3,200
Net Income/Loss:
$-42.79M
P/E Ratio:
-0.000068
EPS:
-7534.7458
Net Cash Flow:
$-25.70M
1W Performance:
-69.83%
1M Performance:
-93.85%
6M Performance:
-99.91%
1Y Performance:
-100.00%
1-Day Range:
$0.4747
$0.8499
1-Week Range:
$0.4747
$1.93
52-Week Range:
$0.4747
$53,451.08
Aditxt Inc Stock (ADTX) Company Profile
Name
Aditxt Inc
Sector
Industry
Phone
909-488-0844
Address
737 N. FIFTH STREET, SUITE 200, RICHMOND
Compare ADTX vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADTX
Aditxt Inc
|
0.5149 | 622.35K | 3,200 | -42.79M | -25.70M | -7,534.75 |
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.03B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.88 | 67.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.46 | 50.76B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.45 | 40.12B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
151.56 | 32.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Aditxt Inc Stock (ADTX) Latest News
Aditxt (NASDAQ: ADTX) asks shareholders to approve reverse stock split through 2027 - Stock Titan
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
$ADTX Stock Is Down 47% Today. Here's What We See in Our Data. - Moomoo
Dow Jumps 250 Points; BJ's Wholesale Shares Fall After Q1 ResultsAditxt (NASDAQ:ADTX), Akari Therapeut - Benzinga
Why Estee Lauder Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Aditxt (NASDAQ: ADTX) Q1 loss deepens as equity turns negative and going concern raised - Stock Titan
Aditxt, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
ADTX stock crashes over 20% after third reverse split in 7 months – retail calls the decline 'unreasonable' - MSN
Nasdaq Down 200 Points; Brady Earnings Top Views - Sahm
Aditxt, Inc.Common Stock (NQ: ADTX - The Chronicle-Journal
ADTX Technical Analysis | Trend, Signals & Chart Patterns | ADITXT INC (NASDAQ:ADTX) - ChartMill
Aditxt Enacts Reverse Stock Split to Maintain Nasdaq Listing - The Globe and Mail
Aditxt Signals Brief Delay in Quarterly Filing - TipRanks
Aditxt (NASDAQ: ADTX) sets 1-for-27 reverse split, cutting shares to ~510K - Stock Titan
Aditxt (ADTX) files Rule 12b-25; Q1 2026 10-Q to follow - Stock Titan
ADTX Stock Crashes Over 20% After Third Reverse Split In 7 Months – Retail Calls The Decline ‘Unreasonable’ - Stocktwits
Aditxt Announces 1-for-27 Reverse Stock Split to Meet Nasdaq Listing Requirement - MEXC Exchange
Aditxt to implement 1-for-27 reverse stock split on May 18 By Investing.com - Investing.com South Africa
Aditxt to implement 1-for-27 reverse stock split on May 18 - Investing.com Australia
Aditxt Announces 1-For-27 Reverse Stk Split >ADTX - Moomoo
Aditxt, Inc. announces 1-for-27 reverse stock split effective at the open of trading on May 18, 2026 - marketscreener.com
Aditxt, Inc. Announces 1-For-27 Reverse Stock Split Effective At The Open Of Trading On May 18, 2026 - TradingView
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-27 Reverse Stock Split Effective at the Open of Trading on May 18, 2026 - FinancialContent
TradingKey - TradingKey
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Aditxt Faces Nasdaq Delisting After Extended Bid-Price Noncompliance - The Globe and Mail
Aditxt, Inc. Receives Nasdaq Delisting Notice on May 6, 2026 – Form 8-K Filing Disclosure - Minichart
Nasdaq moves to delist Aditxt (NASDAQ: ADTX) after $1 bid-price violation - Stock Titan
MSN Money - MSN
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
ADTX - Finviz
Aditxt to implement 1-for-8 reverse stock split on March 9 - Investing.com Nigeria
Aditxt, Inc. Files Form 8-K Current Report with SEC – Company Details, Address, and Nasdaq Listing Information - Minichart
Aditxt Shareholders Approve Reverse Split and Governance Measures - The Globe and Mail
Aditxt Inc Stock (ADTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.98%
1.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):